Naslov
Breast carcinoma with neuroendocrine features: a brief review.

Autori
Jurčić, Petra ; Krušlin, Božo ; Gatalica, Zoran ; Sanati Souzan ; Vranić, Semir

Izvornik
Endocrine oncology and metabolism (1849-8922) 2 (2016), 6; 138-145

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, ostalo

Ključne riječi
Breast cancer ; special types ; neuroendocrine carcinoma ; outcome

Sažetak
Breast carcinoma with neuroendocrine features (BCNF) is a rare entity that is defined by a neuroendocrine (NE) architecture and cytomorphology combined with an immunohistochemical expression of chromogranin A or B and/or synaptophysin. According to the 2012 World Health Organization (WHO) classification, they are classified into three subtypes: invasive breast carcinoma with NE differentiation, well-differentiated NE tumor, and poorly differentiated small cell carcinoma. BCNF are typically positive for the estrogen and progesterone receptor and negative for Her-2/ neu protein. The clinical features are not sufficiently specific to distinguish BCNF from other breast carcinomas. BCNF can mimic benign lesions on mammography, so the additional use of ultrasound or MRI can improve detection. Other imaging tests are useful to detect or rule out metastatic disease. Although standardized treatment guidelines have not yet been established, the mainstay of treatment for early BCNFs is surgery. Adjuvant treatment decisions should be individualized and should take into consideration the prognostic and predictive factors, clinical evidence and the patient’s overall health treatment preferences. Therapeutic options in the metastatic setting include surgery, chemotherapy, peptide receptor radionuclide therapy and molecular-targeted agents. These options are not mutually exclusive and are interchangeable.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA